STOCK TITAN

Ehealth Inc Financials

EHTH
FY2025 annual
Revenue $554.0M +4.1% YoY
Net Income $40.0M +296.0% YoY
EPS (Diluted) -$0.34 +71.4% YoY
Free Cash Flow -$27.6M -34.9% YoY
Source SEC Filings (10-K/10-Q) Data as of Jun 30, 2026 Currency USD FYE December

Ehealth Inc (EHTH) reported $554.0M in revenue for fiscal year 2025, up 4.1% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI EHTH FY2025

Profitability has turned sharply positive, but cash conversion remains negative, showing the business is improving faster on paper than in cash.

Over the last two fiscal years, operating margin moved from -6.4% to 12.0% while overhead stayed essentially flat, so the turnaround appears to come from better fixed-cost absorption and margin recovery rather than a new spending wave. Yet earnings quality is still incomplete: FY2025 net income was $40.0M but operating cash flow was -$25.3M, meaning reported profit still has not become internally generated cash.

Gross profit dollars expanded much faster than sales, climbing from $159.2M to $240.8M over two years. With SG&A discipline holding overhead below its FY2023 level, more of each added revenue dollar reached operating income, which is why profit improved far faster than revenue.

Capital intensity is very low: capex was only $2.3M in FY2025, so free cash flow stays close to operating cash flow and the cash shortfall is operational rather than reinvestment-driven. Liquidity remains workable at 3.4x current ratio, but long-term debt rising to $113.0M shows the balance sheet is carrying more of the funding load while cash generation lags profitability.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Financial health score not available

Ehealth Inc does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Piotroski F-Score Weak
3/9

Ehealth Inc passes 3 of 9 financial strength tests. 2 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), 1 of 2 efficiency signals pass.

Earnings Quality No Cash Backing

For every $1 of reported earnings, Ehealth Inc used $0.63 of operating cash (-$25.3M OCF vs $40.0M net income). Earnings that no cash stands behind rest on accounting accruals, which cannot be repeated indefinitely.

Interest Coverage Safe
6.18x

Ehealth Inc earns $6.18 in operating income for every $1 of interest expense ($66.5M vs $10.8M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$554.0M
YoY+4.1%
5Y CAGR-1.0%
10Y CAGR+10.5%

Ehealth Inc generated $554.0M in revenue in fiscal year 2025. This represents an increase of 4.1% from the prior year.

EBITDA
$68.4M
YoY+167.6%
5Y CAGR+1.1%
10Y CAGR+16.8%

Ehealth Inc's EBITDA was $68.4M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 167.6% from the prior year.

Net Income
$40.0M
YoY+296.0%
5Y CAGR-2.5%
10Y CAGR+26.0%

Ehealth Inc reported $40.0M in net income in fiscal year 2025. This represents an increase of 296.0% from the prior year.

EPS (Diluted)
-$0.34
YoY+71.4%

Ehealth Inc earned -$0.34 per diluted share (EPS) in fiscal year 2025. This represents an increase of 71.4% from the prior year.

Cash & Balance Sheet

Free Cash Flow
-$27.6M
YoY-34.9%

Ehealth Inc recorded an outflow of $27.6M in free cash flow in fiscal year 2025, representing a cash shortfall after capex. This represents a decrease of 34.9% from the prior year.

Cash & Debt
$73.7M
YoY+88.1%
5Y CAGR+11.0%
10Y CAGR+1.6%

Ehealth Inc held $73.7M in cash against $113.0M in long-term debt as of fiscal year 2025.

Shares Outstanding
31M
YoY+3.8%

Ehealth Inc had 31M shares outstanding in fiscal year 2025. This represents an increase of 3.8% from the prior year.

Dividends Per Share

Not reported for fiscal year 2025.

Margins & Returns

Gross Margin
43.5%
YoY+4.3pp
5Y CAGR-55.8pp
10Y CAGR-55.6pp

Ehealth Inc's gross margin was 43.5% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 4.3 percentage points from the prior year.

Operating Margin
12.0%
YoY+7.6pp
5Y CAGR+2.8pp
10Y CAGR+6.9pp

Ehealth Inc's operating margin was 12.0% in fiscal year 2025, reflecting core business profitability. This is up 7.6 percentage points from the prior year.

Net Margin
7.2%
YoY+5.3pp
5Y CAGR-0.6pp
10Y CAGR+5.3pp

Ehealth Inc's net profit margin was 7.2% in fiscal year 2025, showing the share of revenue converted to profit. This is up 5.3 percentage points from the prior year.

Return on Equity
6.8%
YoY+5.0pp
5Y CAGR+1.3pp
10Y CAGR+5.1pp

Ehealth Inc's ROE was 6.8% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 5.0 percentage points from the prior year.

Capital Allocation

R&D Spending
$13.8M
YoY+11.3%
5Y CAGR+8.7%
10Y CAGR+2.7%

Ehealth Inc invested $13.8M in research and development in fiscal year 2025. This represents an increase of 11.3% from the prior year.

Capital Expenditures
$2.3M
YoY+7.4%
5Y CAGR-21.9%
10Y CAGR+1.8%

Ehealth Inc invested $2.3M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 7.4% from the prior year.

Share Buybacks

Not reported for fiscal year 2025.

EHTH Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

EHTH annual income statement
MetricTTMFY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12FY11
Revenue$501.7M$554.0M+4.1%$532.4M+17.6%$452.9M+11.7%$405.4M-24.7%$538.2M-7.6%$582.8M+15.1%$506.2M+101.4%$251.4M+31.8%$190.7M-1.4%$193.3M-4.9%$203.3M+13.2%$179.7M+0.3%$179.2M+15.2%$155.5M+2.5%$151.6M
Cost of RevenueN/A$1.3M-25.7%$1.8M+1.3%$1.8M+7.5%$1.6M-17.3%$2.0M-51.2%$4.1M+49.1%$2.7M+123.0%$1.2M+111.0%$582K-32.5%$862K-55.7%$1.9M-56.7%$4.5M-17.7%$5.5M+14.2%$4.8M-42.6%$8.3M
Gross Profit$222.0M$240.8M+15.5%$208.5M+31.0%$159.2M-60.6%$403.7M-24.7%$536.2M-7.3%$578.7M+14.9%$503.5M+101.3%$250.2M+31.6%$190.1M-1.2%$192.5M-4.4%$201.4M+15.0%$175.2M+0.8%$173.7M+15.3%$150.7M+5.2%$143.3M
R&D ExpensesN/A$13.8M+11.3%$12.4M-9.5%$13.7M+13.2%$12.1M+16.3%$10.4M+14.3%$9.1M+12.3%$8.1M+17.4%$6.9M-9.2%$7.6M-14.6%$8.9M-16.0%$10.6M-12.4%$12.1M+19.8%$10.1M+20.2%$8.4M+15.1%$7.3M
SG&A Expenses$81.8M$89.6M-0.2%$89.8M-9.7%$99.4M+38.4%$71.8M-5.1%$75.7M-1.0%$76.5M+19.2%$64.2M+40.0%$45.8M+14.7%$40.0M+13.5%$35.2M+16.5%$30.2M+9.8%$27.5M-5.8%$29.2M+11.7%$26.2M-1.6%$26.6M
Operating Income$54.4M$66.5M+182.1%$23.6M+181.1%-$29.1M+71.7%-$102.7M+18.3%-$125.6M-335.6%$53.3M-34.5%$81.4M+3091.3%$2.6M+127.0%-$9.5M-434.8%$2.8M-72.8%$10.4M+253.6%-$6.8M-281.2%$3.7M-72.2%$13.4M+1.5%$13.2M
Interest Expense$13.9M$10.8M-3.6%$11.2M+1.7%$11.0M+43.9%$7.6M+802.6%$845KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Income Tax$15.1M$18.7M+101.9%$9.3M+488.7%-$2.4M+86.5%-$17.7M+13.9%-$20.5M-340.3%$8.5M-48.6%$16.6M+442.0%$3.1M+109.1%-$33.7M-1018.6%$3.7M-52.4%$7.7M-17.5%$9.3M+387.5%$1.9M-69.9%$6.4M-1.4%$6.5M
Net Income$27.1M$40.0M+296.0%$10.1M+135.8%-$28.2M+68.2%-$88.7M+15.0%-$104.4M-329.6%$45.5M-32.0%$66.9M+27653.9%$241K-99.1%$25.4M+8263.8%$304K-92.3%$4.0M+124.5%-$16.2M-1040.5%$1.7M-75.7%$7.1M+5.3%$6.7M
EPS (Diluted)-$0.34+71.4%-$1.19+49.8%-$2.37-$4.36+5.0%-$4.59-373.2%$1.68-38.5%$2.73+27200.0%$0.01-99.2%$1.33+6550.0%$0.02-90.9%$0.22+125.0%-$0.88-1077.8%$0.09-73.5%$0.34+9.7%$0.31

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.

EHTH Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

EHTH annual balance sheet
MetricFY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12FY11
Total Assets$1.3B+9.3%$1.2B+3.8%$1.1B+0.1%$1.1B-3.2%$1.1B+10.5%$1.0B+40.2%$741.6M+68.8%$439.3M+22.3%$359.1M+0.4%$357.7M+215.6%$113.3M+6.2%$106.7M-35.9%$166.4M-15.2%$196.3M+10.3%$177.9M
Current Assets$334.4M-5.7%$354.5M-7.3%$382.4M-4.7%$401.1M-1.6%$407.6M+23.1%$331.0M+59.0%$208.1M+33.3%$156.2M+0.3%$155.7M-9.7%$172.5M+122.5%$77.5M+16.6%$66.5M-46.6%$124.5M-20.2%$156.1M+11.7%$139.7M
Cash & Equivalents$73.7M+88.1%$39.2M-66.1%$115.7M-19.9%$144.4M+76.3%$81.9M+87.2%$43.8M+86.5%$23.5M+79.3%$13.1M-67.5%$40.3M-34.8%$61.8M-1.5%$62.7M+22.0%$51.4M-52.0%$107.1M-24.0%$140.8M+13.9%$123.6M
Accounts Receivable$7.7M-54.3%$16.8M+320.9%$4.0M+51.7%$2.6M-54.2%$5.8M+219.6%$1.8M-22.9%$2.3M-35.2%$3.6M+144.1%$1.5M-24.3%$1.9M-79.8%$9.6M+17.6%$8.2M+78.8%$4.6M+2.6%$4.5M-44.5%$8.1M
GoodwillN/AN/A$0$0$0-100.0%$40.2M0.0%$40.2M0.0%$40.2M+185.4%$14.1M0.0%$14.1M0.0%$14.1M0.0%$14.1M0.0%$14.1M0.0%$14.1M0.0%$14.1M
Total Liabilities$670.9M+18.3%$567.0M+11.8%$507.3M+9.9%$461.7M+15.5%$399.8M+97.5%$202.5M-5.6%$214.5M+57.5%$136.1M+87.9%$72.5M-31.3%$105.4M+185.8%-$122.9M-4.3%-$117.8M-452.7%$33.4M+31.4%$25.4M+14.2%$22.3M
Current Liabilities$99.1M+3.2%$96.0M+22.2%$78.5M+29.7%$60.6M-19.7%$75.5M-10.6%$84.4M-25.3%$113.0M+86.4%$60.6M+138.2%$25.4M-1.1%$25.7M-19.4%$31.9M+19.4%$26.7M-1.9%$27.2M+30.9%$20.8M+13.4%$18.4M
Long-Term Debt$113.0M+65.0%$68.5M+1.0%$67.8M+2.5%$66.1M$0N/A$0-100.0%$5.0M$0N/AN/AN/AN/AN/AN/A
Total Equity$591.6M+0.5%$588.4M-2.9%$606.0M-6.9%$651.0M-13.2%$749.5M-10.5%$837.6M+58.9%$527.2M+73.9%$303.1M+5.8%$286.7M+13.6%$252.3M+6.8%$236.2M+5.2%$224.5M+68.8%$133.0M-22.2%$170.9M+9.8%$155.7M
Retained Earnings$30.1M+97.5%$15.2M+109.3%$7.3M-90.1%$73.8M-61.8%$193.2M-38.9%$316.2M+16.3%$271.9M+32.6%$205.0M+0.1%$204.7M+14.2%$179.3M+1787.7%$9.5M-33.4%$14.3M-53.2%$30.5M+6.0%$28.7M+32.7%$21.7M

Not reported in any period shown, so not listed: Inventory.

EHTH Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

EHTH annual cash flow statement
MetricTTMFY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12FY11
Operating Cash Flow-$30.5M-$25.3M-38.0%-$18.4M-174.4%-$6.7M+75.1%-$26.9M+83.5%-$162.6M-50.8%-$107.9M-50.9%-$71.5M-2113.4%-$3.2M+79.2%-$15.5M-480.6%$4.1M-70.2%$13.7M+669.9%$1.8M-91.5%$20.9M-15.8%$24.9M+10.4%$22.5M
Capital Expenditures$1.0M$2.3M+7.4%$2.1M+0.4%$2.1M+874.8%$214K-94.5%$3.9M-50.1%$7.8M+16.7%$6.6M+46.5%$4.5M+142.7%$1.9M-1.1%$1.9M+0.5%$1.9M-47.9%$3.6M-50.8%$7.3M+90.1%$3.9M+60.1%$2.4M
Free Cash Flow-$31.5M-$27.6M-34.9%-$20.5M-133.1%-$8.8M+67.6%-$27.1M+83.7%-$166.5M-44.0%-$115.6M-48.0%-$78.1M-906.3%-$7.8M+55.4%-$17.4M-893.5%$2.2M-81.4%$11.8M+747.5%-$1.8M-113.4%$13.6M-35.3%$21.0M+4.5%$20.1M
Investing Cash Flow-$2.4M$25.4M+152.5%-$48.4M-204.7%-$15.9M-161.5%$25.9M+304.7%-$12.6M+82.8%-$73.3M-332.5%-$16.9M+34.2%-$25.8M-407.2%-$5.1M-36.3%-$3.7M-24.4%-$3.0M+63.0%-$8.1M-10.6%-$7.3M+27.4%-$10.1M-53.0%-$6.6M
Financing Cash Flow$35.6M$34.3M+454.4%-$9.7M-55.4%-$6.2M-109.7%$63.8M-70.1%$213.2M+6.0%$201.2M+97.0%$102.1M+5391.5%$1.9M+313.8%-$870K+31.4%-$1.3M-319.9%$577K+101.2%-$49.3M-4.1%-$47.4M-2042.7%$2.4M+112.0%-$20.4M
Share BuybacksN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A$0$0-100.0%$50.0M-15.3%$59.0M+525.5%$9.4M-62.8%$25.4M

Not reported in any period shown, so not listed: Dividends Paid.

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.

EHTH Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples.

EHTH annual financial ratios
MetricFY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12FY11
Gross Margin43.5%+4.3pp39.1%+4.0pp35.1%-64.4pp99.6%0.0pp99.6%+0.3pp99.3%-0.2pp99.5%0.0pp99.5%-0.2pp99.7%+0.1pp99.6%+0.5pp99.0%+1.5pp97.5%+0.5pp97.0%0.0pp96.9%+2.4pp94.5%
Operating Margin12.0%+7.6pp4.4%+10.8pp-6.4%+18.9pp-25.3%-2.0pp-23.4%-32.5pp9.2%-6.9pp16.1%+15.1pp1.0%+6.0pp-5.0%-6.4pp1.5%-3.6pp5.1%+8.9pp-3.8%-5.8pp2.1%-6.6pp8.6%-0.1pp8.7%
Net Margin7.2%+5.3pp1.9%+8.1pp-6.2%+15.7pp-21.9%-2.5pp-19.4%-27.2pp7.8%-5.4pp13.2%+13.1pp0.1%-13.2pp13.3%+13.2pp0.2%-1.8pp1.9%+11.0pp-9.0%-10.0pp1.0%-3.6pp4.6%+0.1pp4.4%
Return on Equity6.8%+5.0pp1.7%+6.4pp-4.7%+9.0pp-13.6%+0.3pp-13.9%-19.4pp5.4%-7.3pp12.7%+12.6pp0.1%-8.8pp8.9%+8.8pp0.1%-1.6pp1.7%+8.9pp-7.2%-8.5pp1.3%-2.8pp4.1%-0.2pp4.3%
Return on Assets3.2%+2.3pp0.9%+3.4pp-2.5%+5.4pp-8.0%+1.1pp-9.1%-13.5pp4.4%-4.7pp9.0%+9.0pp0.1%-7.0pp7.1%+7.0pp0.1%-3.4pp3.5%+18.7pp-15.2%-16.2pp1.0%-2.6pp3.6%-0.2pp3.8%
Current Ratio3.37-0.3x3.69-1.2x4.87-1.8x6.62+1.2x5.40+1.5x3.92+2.1x1.84-0.7x2.58-3.5x6.12-0.6x6.70+4.3x2.43-0.1x2.49-2.1x4.57-2.9x7.50-0.1x7.61
Debt-to-Equity0.19+0.1x0.120.0x0.110.0x0.10+0.1x0.00-0.2x0.24+0.2x0.000.0x0.020.0x0.00-0.4x0.42N/AN/A0.25+0.1x0.150.0x0.14
FCF Margin-5.0%-1.1pp-3.8%-1.9pp-1.9%+4.7pp-6.7%+24.3pp-30.9%-11.1pp-19.8%-4.4pp-15.4%-12.4pp-3.1%+6.0pp-9.1%-10.3pp1.1%-4.7pp5.8%+6.8pp-1.0%-8.6pp7.6%-5.9pp13.5%+0.3pp13.3%

Similar Companies

Frequently Asked Questions

What is Ehealth Inc's annual revenue?

Ehealth Inc (EHTH) reported $554.0M in total revenue for fiscal year 2025. This represents a 4.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Ehealth Inc's revenue growing?

Ehealth Inc (EHTH) revenue grew by 4.1% year-over-year, from $532.4M to $554.0M in fiscal year 2025.

Is Ehealth Inc profitable?

Yes, Ehealth Inc (EHTH) reported a net income of $40.0M in fiscal year 2025, with a net profit margin of 7.2%.

Ehealth Inc (EHTH) reported diluted earnings per share of -$0.34 for fiscal year 2025. This represents a 71.4% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Ehealth Inc (EHTH) had EBITDA of $68.4M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2025, Ehealth Inc (EHTH) had $73.7M in cash and equivalents against $113.0M in long-term debt.

Ehealth Inc (EHTH) had a gross margin of 43.5% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Ehealth Inc (EHTH) had an operating margin of 12.0% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Ehealth Inc (EHTH) had a net profit margin of 7.2% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Ehealth Inc (EHTH) has a return on equity of 6.8% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Ehealth Inc (EHTH) recorded an outflow of $27.6M in free cash flow during fiscal year 2025. This represents a -34.9% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Ehealth Inc (EHTH) recorded an outflow of $25.3M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

Ehealth Inc (EHTH) had $1.3B in total assets as of fiscal year 2025, including both current and long-term assets.

Ehealth Inc (EHTH) invested $2.3M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Ehealth Inc (EHTH) invested $13.8M in research and development during fiscal year 2025.

Ehealth Inc (EHTH) had 31M shares outstanding as of fiscal year 2025.

Ehealth Inc (EHTH) had a current ratio of 3.37 as of fiscal year 2025, which is generally considered healthy.

Ehealth Inc (EHTH) had a debt-to-equity ratio of 0.19 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Ehealth Inc (EHTH) had a return on assets of 3.2% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Based on fiscal year 2025 data, Ehealth Inc (EHTH) had $73.7M in cash against an annual operating cash burn of $25.3M. This gives an estimated cash runway of approximately 35 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

Ehealth Inc (EHTH) has a Piotroski F-Score of 3 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

For every $1 of reported earnings, Ehealth Inc (EHTH) used $0.63 of operating cash (-$25.3M OCF vs $40.0M net income). Earnings that no cash stands behind rest on accounting accruals, which cannot be repeated indefinitely. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Ehealth Inc (EHTH) has an interest coverage ratio of 6.18x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Back to top